UA Researchers Looking For Genes Behind ALS
A UA research team is trying to solve the mystery behind amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. BIO5 member and molecular biologist Dr. Daniela Zarnescu is using a catalog of genetic information to sift through a list of drugs that could provide clues to successfully battle the disease.
|
|
|
Passing Five Year Milestone, UA Breaks Commercialization Records Again, Looks Ahead To New Phase
The UA has surpassed its performance expectations for key annual measures in technology commercialization, and five of the 16 new startups formed in the last year were generated from research conducted by BIO5 Institute members. Reglagene, Regulonix, Aqualung Therapeutics, Iluminos Therapeutics, and MCR Therapeutics are companies using cutting edge research to solve health problems and cure disease.
|
|
|
Queen Bees And The Microbial Fountain of Youth
UA students study honey bees to find out how bacteria in their guts and the foods they eat are connected to life expectancy. They hope the insects can serve as model systems to discover clues about how genetics, gut bacteria and diet influence aging in humans. The study resulted from an interdisciplinary collaboration between the UA, the BIO5 Institute and the Carl Hayden Bee Research Center.
|
|
|
McCarthy's $95 Million Valley Fever Bill Would Boost Research, Drug Development
Recent legislation is being hailed by Valley Fever advocates and researchers as a huge step forward in combating the disease, which is on the rise locally. “I think (the bill) is appropriately drawing attention to a problem which is every bit as intense as polio was before its vaccine for the susceptible populations,” said BIO5's Dr. John Galgiani, Director of the UA Valley Fever Center for Excellence.
|
|
|
Researchers Identifying Algorithms To Increase Relevant Drug Interaction Alerts
Drug interactions can pose a serious risk to patients when they are not identified and addressed. That is why a team of UA researchers, including BIO5's Dr. Vignesh Subbian, Assistant Professor in the Department of Biomedical Engineering and the Department of Systems & Industrial Engineering, are developing a drug interaction knowledge database, combined with clinically validated algorithms, which is expected to increase the specificity of warnings concerning dangerous drug combinations.
|
|
|
|
|
OCT. 18, 2018
Ecosystems Genomics Seminar Series
LEARN MORE
|
|
|
|
OCT. 23, 2018
Resilience And Independence In Aging Seminar
LEARN MORE
|
|
|
|
OCT. 25, 2018
Ecosystems Genomics Seminar Series
LEARN MORE
|
|
|
|
|
|
|
|
